# Spironolactone in CKD Enabled by Chlorthalidone: PILOT

> **NCT05222191** · PHASE2 · UNKNOWN · sponsor: **Indiana Institute for Medical Research** · enrollment: 24 (estimated)

## Conditions studied

- Renal Insufficiency
- Chronic Hypertension

## Interventions

- **DRUG:** Spironolactone
- **DRUG:** Chlorthalidone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05222191
- **Lead sponsor:** Indiana Institute for Medical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2023-12-12
- **Final completion:** 2023-12-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05222191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05222191, "Spironolactone in CKD Enabled by Chlorthalidone: PILOT". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05222191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*